tiprankstipranks
Sanofi (MX:SNYN)
:SNYN
Mexico Market

Sanofi (SNYN) Ratios

0 Followers

Sanofi Ratios

MX:SNYN's free cash flow for Q2 2026 was €0.75. For the 2026 fiscal year, MX:SNYN's free cash flow was decreased by € and operating cash flow was €0.09. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
0.99 1.09 1.46 1.27 1.42
Quick Ratio
0.23 0.73 1.14 0.87 1.05
Cash Ratio
0.20 0.27 0.26 0.36 0.53
Solvency Ratio
0.10 0.24 0.17 0.19 0.22
Operating Cash Flow Ratio
0.54 0.43 0.31 0.42 0.44
Short-Term Operating Cash Flow Coverage
2.46 2.79 2.16 4.42 2.36
Net Current Asset Value
€ -27.97B€ -24.14B€ -12.35B€ -21.46B€ -17.54B
Leverage Ratios
Debt-to-Assets Ratio
0.18 0.16 0.13 0.15 0.17
Debt-to-Equity Ratio
0.34 0.28 0.23 0.25 0.28
Debt-to-Capital Ratio
0.25 0.22 0.19 0.20 0.22
Long-Term Debt-to-Capital Ratio
0.17 0.17 0.13 0.16 0.17
Financial Leverage Ratio
1.86 1.78 1.71 1.71 1.69
Debt Service Coverage Ratio
0.91 2.30 2.03 3.66 2.40
Interest Coverage Ratio
13.79 15.33 11.65 13.57 26.41
Debt to Market Cap
0.23 0.18 0.14 0.15 0.17
Interest Debt Per Share
10.16 8.59 7.40 7.67 8.63
Net Debt to EBITDA
2.09 1.02 0.95 0.88 0.63
Profitability Margins
Gross Profit Margin
72.77%72.07%70.18%69.66%70.71%
EBIT Margin
12.60%14.56%16.82%16.73%25.65%
EBITDA Margin
16.86%26.71%24.91%27.37%33.31%
Operating Profit Margin
20.58%20.54%16.38%16.72%25.05%
Pretax Profit Margin
10.62%12.89%15.26%14.69%24.63%
Net Profit Margin
8.09%16.72%12.55%12.98%20.64%
Continuous Operations Profit Margin
8.16%10.65%12.54%12.25%19.93%
Net Income Per EBT
76.19%129.78%82.27%88.31%83.78%
EBT Per EBIT
51.60%62.73%93.19%87.86%98.33%
Return on Assets (ROA)
3.07%6.16%4.19%4.27%6.61%
Return on Equity (ROE)
5.52%10.95%7.17%7.29%11.19%
Return on Capital Employed (ROCE)
10.37%9.75%7.00%6.81%9.89%
Return on Invested Capital (ROIC)
7.41%7.70%5.51%5.53%7.67%
Return on Tangible Assets
6.52%13.19%8.33%10.24%15.17%
Earnings Yield
4.30%7.76%4.77%4.77%7.39%
Efficiency Ratios
Receivables Turnover
5.31 4.23 4.17 3.77 3.77
Payables Turnover
0.56 1.77 1.75 1.72 1.74
Inventory Turnover
0.55 1.28 1.40 1.31 1.33
Fixed Asset Turnover
4.09 4.06 3.82 3.52 3.47
Asset Turnover
0.38 0.37 0.33 0.33 0.32
Working Capital Turnover Ratio
-388.25 5.83 4.45 5.04 4.20
Cash Conversion Cycle
83.13 166.11 139.57 164.40 162.65
Days of Sales Outstanding
68.69 86.30 87.60 96.82 96.70
Days of Inventory Outstanding
660.88 285.70 260.68 279.39 275.24
Days of Payables Outstanding
646.44 205.90 208.72 211.81 209.29
Operating Cycle
729.57 372.01 348.29 376.21 371.94
Cash Flow Ratios
Operating Cash Flow Per Share
7.22 4.97 3.63 4.10 4.20
Free Cash Flow Per Share
6.89 4.16 2.35 3.45 3.32
CapEx Per Share
0.33 0.81 1.28 0.65 0.88
Free Cash Flow to Operating Cash Flow
0.95 0.84 0.65 0.84 0.79
Dividend Paid and CapEx Coverage Ratio
3.02 1.65 1.15 1.69 1.65
Capital Expenditure Coverage Ratio
21.78 6.10 2.84 6.34 4.78
Operating Cash Flow Coverage Ratio
0.73 0.60 0.51 0.55 0.50
Operating Cash Flow to Sales Ratio
0.35 0.26 0.21 0.25 0.26
Free Cash Flow Yield
17.86%10.08%5.05%7.63%7.35%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
23.50 12.89 21.22 20.97 13.53
Price-to-Sales (P/S) Ratio
1.89 2.15 2.63 2.72 2.79
Price-to-Book (P/B) Ratio
1.33 1.41 1.50 1.53 1.51
Price-to-Free Cash Flow (P/FCF) Ratio
5.60 9.92 19.80 13.11 13.60
Price-to-Operating Cash Flow Ratio
5.33 8.30 12.84 11.04 10.76
Price-to-Earnings Growth (PEG) Ratio
-0.36 0.28 11.43 -0.65 0.48
Price-to-Fair Value
1.33 1.41 1.50 1.53 1.51
Enterprise Value Multiple
13.27 9.08 11.51 10.82 9.01
Enterprise Value
109.50B 113.34B 127.03B 123.23B 121.72B
EV to EBITDA
13.27 9.08 11.51 10.82 9.01
EV to Sales
2.24 2.43 2.87 2.96 3.00
EV to Free Cash Flow
6.65 11.17 21.58 14.26 14.62
EV to Operating Cash Flow
6.34 9.34 13.99 12.01 11.56
Tangible Book Value Per Share
0.52 1.70 4.73 0.25 1.45
Shareholders’ Equity Per Share
28.92 29.24 30.97 29.58 29.87
Tax and Other Ratios
Effective Tax Rate
0.23 0.17 0.18 0.17 0.19
Revenue Per Share
20.44 19.14 17.69 16.62 16.20
Net Income Per Share
1.65 3.20 2.22 2.16 3.34
Tax Burden
0.76 1.30 0.82 0.88 0.84
Interest Burden
0.84 0.89 0.91 0.88 0.96
Research & Development to Revenue
0.17 0.17 0.17 0.16 0.16
SG&A to Revenue
0.22 0.22 0.21 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 <0.01
Income Quality
2.07 2.18 1.65 1.90 1.26
Currency in EUR